Login

Healthcare

00:00:00
Enzymatica presents positive in-vitro results | August 2023 - Claus Egstrand,CEO, Enzymatica AB (publ)
00:00:00
Interview with Pål Ryfors (CEO, Episurf Medical)
00:00:00
Ergomed in robust shape to keep delivering - Jonathan Curtain, CFO, Ergomed
00:00:00
Interest in Ergomed's blood thickener 'significant' - CEO Miroslav Reljanovic, Ergomed
00:00:00
Ergomed cheers 'very strong' performance in first half of 2022 -
00:00:00
Ergomed announce £25mln acquisition - Miroslav Reljanović, CEO, Ergomed
00:00:00
Evgen Pharma "very busy" at start of "exciting year" - Dr Huw Jones, CEO, Evgen Pharma
00:00:00
Interview with Jodie Gilmore, Global Orthopedic Business Director at Elos Medtech
00:00:00
Evgen Pharma "delighted" with cash position after promising first half - Dr Huw Jones , CEO, Evgen Pharma
00:00:00
Evgen Pharma talks through clinical milestones and financial results from its 2022 full year report - Huw Jones, CEO, Evgen Pharma
00:00:00
Executive interview – Dr Heikki Lanckriet, CEO, Expedeon
00:00:00
EyeGate Pharma Moving Fast Toward Commercialization - Stephen From , CEO, EyeGate Pharmaceuticals Inc
00:00:00
From the operating room to the C-suite in pharma - Jay S. Duker, MD President & CEO and Board Director, Eyepoint Pharmaceuticals Inc
00:00:00
Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals
00:00:00
Faron Pharmaceuticals Oy excited by green light for trials of promising anti-cancer treatment - Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals
00:00:00
Faron Pharmaceuticals CEO delighted with latest BEXMAB study findings - Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals

© 2017 - Neuhu+